Baudax Bio Inc.

NASDAQ: BXRX · Real-Time Price · USD
0.02
-0.00 (-1.48%)
At close: Feb 29, 2024, 9:53 PM

Baudax Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-58.8M -19.77M
Depreciation & Amortization
2.16M 2.82M
Stock-Based Compensation
1.4M 4.79M
Other Working Capital
1.44M 921K
Other Non-Cash Items
27.38M -32.41M
Deferred Income Tax
n/a -1.61M
Change in Working Capital
62K -3.08M
Operating Cash Flow
-27.79M -49.27M
Capital Expenditures
-20K -203K
Cash Acquisitions
n/a -9K
Purchase of Investments
n/a -19.64M
Sales Maturities Of Investments
n/a 19.65M
Other Investing Acitivies
n/a 9K
Investing Cash Flow
-20K -194K
Debt Repayment
n/a n/a
Common Stock Repurchased
-3K -97K
Dividend Paid
n/a n/a
Other Financial Acitivies
17.18M 35.01M
Financial Cash Flow
17.18M 35.01M
Net Cash Flow
-10.63M -14.45M
Free Cash Flow
-27.81M -49.47M